Page last updated: 2024-12-06

medicarpin, (6as-cis)-isomer

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

(+)-medicarpin : The (+)-enantiomer of medicarpin. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID73067
CHEMBL ID413297
CHEBI ID6714
SCHEMBL ID19999732
MeSH IDM0322591

Synonyms (22)

Synonym
CHEBI:6714 ,
(6as,11as)-9-methoxy-6a,11a-dihydro-6h-[1]benzofuro[3,2-c]chromen-3-ol
(+)-medicarpin
33983-39-0
C01729
CHEMBL413297
(6as,11as)-medicarpan
(6as,11as)-medicarpin
(6as,11as)-demethylhomopterocarpin
(+)-medicrpin
(6as, 11as)-medicarpin
SCHEMBL19999732
Q27107309
CS-0032253
HY-N6052
(6as,11as)-9-methoxy-6a,11a-dihydro-6h-benzofuro[3,2-c]chromen-3-ol
(+/-)-medicarpin
DTXSID80872005
(1s,10s)-14-methoxy-8,17-dioxatetracyclo[8.7.0.0?,?.0??,??]heptadeca-2(7),3,5,11,13,15-hexaen-5-ol
AKOS040740841
(+)-(6as,11as)-medicarpin
9-methoxy-6a,11a-dimethyl-6a,11a-dihydro-6h-\\ 1-benzofuro[3,2-c]chromen-3-ol from dalbergia oliveri
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
medicarpinA member of the class of pterocarpans that is 3-hydroxyptercarpan with a methoxy substituent at position 9.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (24)

Assay IDTitleYearJournalArticle
AID379755Antimicrobial activity against Pseudomonas aeruginosa PA14 by twofold serial dilution method2006Journal of natural products, Feb, Volume: 69, Issue:2
Metabolites of the "smoke tree", Dalea spinosa, potentiate antibiotic activity against multidrug-resistant Staphylococcus aureus.
AID404184Cytotoxicity against human HT1080 cells after 72 hrs by MTT assay2008Bioorganic & medicinal chemistry, May-15, Volume: 16, Issue:10
Cytotoxic constituents from Brazilian red propolis and their structure-activity relationship.
AID379754Antimicrobial activity against wild-type Escherichia coli K12 by twofold serial dilution method2006Journal of natural products, Feb, Volume: 69, Issue:2
Metabolites of the "smoke tree", Dalea spinosa, potentiate antibiotic activity against multidrug-resistant Staphylococcus aureus.
AID379763Inhibition of NorA efflux pump in Staphylococcus aureus K1758 mutant assessed as fold reduction of berberine MIC at 56 uM by twofold serial dilution method2006Journal of natural products, Feb, Volume: 69, Issue:2
Metabolites of the "smoke tree", Dalea spinosa, potentiate antibiotic activity against multidrug-resistant Staphylococcus aureus.
AID1328377Anthelmintic activity against Ancylostoma ceylanicum isolated from infected Syrian hamster feces assessed as survival rate at 25 ug/ml measured on day 4 relative to control2016Journal of natural products, 09-23, Volume: 79, Issue:9
Phenolic Metabolites of Dalea ornata Affect Both Survival and Motility of the Human Pathogenic Hookworm Ancylostoma ceylanicum.
AID379753Antimicrobial activity against wild-type Staphylococcus aureus 8325-4 by twofold serial dilution method2006Journal of natural products, Feb, Volume: 69, Issue:2
Metabolites of the "smoke tree", Dalea spinosa, potentiate antibiotic activity against multidrug-resistant Staphylococcus aureus.
AID379761Inhibition of NorA efflux pump in wild-type Staphylococcus aureus 8325-4 assessed as fold reduction of berberine MIC at 56 uM by twofold serial dilution method2006Journal of natural products, Feb, Volume: 69, Issue:2
Metabolites of the "smoke tree", Dalea spinosa, potentiate antibiotic activity against multidrug-resistant Staphylococcus aureus.
AID1328375Anthelmintic activity against Ancylostoma ceylanicum isolated from infected Syrian hamster feces assessed as survival rate at 25 ug/ml measured on day 2 relative to control2016Journal of natural products, 09-23, Volume: 79, Issue:9
Phenolic Metabolites of Dalea ornata Affect Both Survival and Motility of the Human Pathogenic Hookworm Ancylostoma ceylanicum.
AID379752Inhibition of NorA efflux pump in Staphylococcus aureus K2361 mutant overexpressing NorA assessed as potentiation of berberine-induced antimicrobial activity at 56 uM by twofold serial dilution method2006Journal of natural products, Feb, Volume: 69, Issue:2
Metabolites of the "smoke tree", Dalea spinosa, potentiate antibiotic activity against multidrug-resistant Staphylococcus aureus.
AID1328379Effect on Syrian hamster splenocytes proliferation assessed as stimulation index by BrdU-incorporation based colorimetric analysis2016Journal of natural products, 09-23, Volume: 79, Issue:9
Phenolic Metabolites of Dalea ornata Affect Both Survival and Motility of the Human Pathogenic Hookworm Ancylostoma ceylanicum.
AID404182Cytotoxicity against human A549 cells after 72 hrs by MTT assay2008Bioorganic & medicinal chemistry, May-15, Volume: 16, Issue:10
Cytotoxic constituents from Brazilian red propolis and their structure-activity relationship.
AID313354Cytotoxicity against human PANC1 cells in nutrient deprived medium after 24 hrs2008Bioorganic & medicinal chemistry, Jan-01, Volume: 16, Issue:1
Constituents of Brazilian red propolis and their preferential cytotoxic activity against human pancreatic PANC-1 cancer cell line in nutrient-deprived condition.
AID358614Cytotoxicity against human KB cells2001Journal of natural products, Nov, Volume: 64, Issue:11
Macharistol, a new cytotoxic cinnamylphenol from the stems of Machaerium aristulatum.
AID379756Antimicrobial activity against Saccharomyces cerevisiae BY4742 by twofold serial dilution method2006Journal of natural products, Feb, Volume: 69, Issue:2
Metabolites of the "smoke tree", Dalea spinosa, potentiate antibiotic activity against multidrug-resistant Staphylococcus aureus.
AID404183Cytotoxicity against human HeLa cells after 72 hrs by MTT assay2008Bioorganic & medicinal chemistry, May-15, Volume: 16, Issue:10
Cytotoxic constituents from Brazilian red propolis and their structure-activity relationship.
AID404180Cytotoxicity against mouse B16-BL6 cells after 72 hrs by MTT assay2008Bioorganic & medicinal chemistry, May-15, Volume: 16, Issue:10
Cytotoxic constituents from Brazilian red propolis and their structure-activity relationship.
AID379766Antimicrobial activity against Enterococcus faecalis V583 by twofold serial dilution method2006Journal of natural products, Feb, Volume: 69, Issue:2
Metabolites of the "smoke tree", Dalea spinosa, potentiate antibiotic activity against multidrug-resistant Staphylococcus aureus.
AID404179Cytotoxicity against mouse colon 26-L5 cells after 72 hrs by MTT assay2008Bioorganic & medicinal chemistry, May-15, Volume: 16, Issue:10
Cytotoxic constituents from Brazilian red propolis and their structure-activity relationship.
AID404181Cytotoxicity against mouse LLC cells after 72 hrs by MTT assay2008Bioorganic & medicinal chemistry, May-15, Volume: 16, Issue:10
Cytotoxic constituents from Brazilian red propolis and their structure-activity relationship.
AID1328376Anthelmintic activity against Ancylostoma ceylanicum isolated from infected Syrian hamster feces assessed as survival rate at 25 ug/ml measured on day 3 relative to control2016Journal of natural products, 09-23, Volume: 79, Issue:9
Phenolic Metabolites of Dalea ornata Affect Both Survival and Motility of the Human Pathogenic Hookworm Ancylostoma ceylanicum.
AID1328378Anthelmintic activity against Ancylostoma ceylanicum isolated from infected Syrian hamster feces assessed as survival rate at 25 ug/ml measured on day 5 (Rvb = >95%)2016Journal of natural products, 09-23, Volume: 79, Issue:9
Phenolic Metabolites of Dalea ornata Affect Both Survival and Motility of the Human Pathogenic Hookworm Ancylostoma ceylanicum.
AID379757Antimicrobial activity against Candida albicans F5 by twofold serial dilution method2006Journal of natural products, Feb, Volume: 69, Issue:2
Metabolites of the "smoke tree", Dalea spinosa, potentiate antibiotic activity against multidrug-resistant Staphylococcus aureus.
AID379758Inhibition of MDR protein in wild-type Staphylococcus aureus 8325-4 assessed as potentiation of antimicrobial activity of berberine after 18 hrs by twofold serial dilution method2006Journal of natural products, Feb, Volume: 69, Issue:2
Metabolites of the "smoke tree", Dalea spinosa, potentiate antibiotic activity against multidrug-resistant Staphylococcus aureus.
AID1328374Anthelmintic activity against Ancylostoma ceylanicum isolated from infected Syrian hamster feces assessed as survival rate at 25 ug/ml measured on day 1 relative to control2016Journal of natural products, 09-23, Volume: 79, Issue:9
Phenolic Metabolites of Dalea ornata Affect Both Survival and Motility of the Human Pathogenic Hookworm Ancylostoma ceylanicum.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (80.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.50

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.50 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.30 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.50)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]